About this Research Topic
At present, according to UNESCO, less than 30% of researchers worldwide are women. Long-standing biases and gender stereotypes are discouraging girls and women away from science-related fields, and STEM research in particular. Science and gender equality are, however, essential to ensure sustainable development as highlighted by UNESCO. In order to change traditional mindsets, gender equality must be promoted, stereotypes defeated, and girls and women should be encouraged to pursue STEM careers.
Frontiers in Pharmacology presents this Research Topic to promote the work of women scientists, across all areas of Drugs Outcomes Research and Policies with a focus on: Real-World Evidence (RWE), Patient-Centered Research, Digital Health, Integrated Care, Value-Based Health Care, Cost-Effectiveness (CEA) and Cost-Utility Analysis (CUA), and Drug Innovation Pipeline & New Drug Funding Models .
We especially welcome manuscripts where to be considered for this collection, the first or last author should be a researcher who identifies themselves as female.
For this Research Topic, we will welcome manuscripts covering:
• Real-World Evidence (RWE) on the effectiveness and/or safety of medicines and other health technologies (e.g., medical devices, medical procedures, public health interventions, health care services), using patient-level data from electronic medical records, electronic health records, prescription/dispensing claims, patient/disease registries, lab & diagnostics databases, etc.
• Patient-Centered Research, namely quality-of-life & Patient-Reported Outcomes (PROs), health preference research (e.g., Discrete Choice Experiments, Best/Worst scales, Multi Criteria Decision Analysis), patient satisfaction, and medication adherence and persistence.
• Digital Health, using digital therapeutics, patient wearables, connected biometric sensors, smartphone cameras, clinical trial patient remote tools, in-home connected virtual assistants, apps, telemedicine/telehealth, personal health records, web-based surveys, social media, and/or patient apps.
• Integrated Care studies, addressing a coherent set of methods on the funding (e.g. prepaid capitation), administrative (e.g. joint commissioning), organizational (e.g. jointly managed programs), service delivery (e.g. multidisciplinary teamwork) and clinical levels (e.g. common care pathways) for patients with complex, long term problems cutting across multiple services, providers and settings.
• Value-Based Health Care studies, namely standard sets of outcomes, changes in patient outcomes, cost analysis using Time-Driven Activity-Based Costing (TDABC), in a particular disease therapy and healthcare setting.
• Cost-Effectiveness (CEA) and Cost-Utility Analysis (CUA) of medicines and other health technologies (e.g., medical devices, medical procedures, public health interventions, health care services).
• Drug Innovation Pipeline & New Drug Funding Models, particularly looking at therapy areas and indications, new mechanisms of action and routes of administration in the drug innovation pipeline, high costs, and new models for payers to fund these therapies.
The following article types can be submitted to the Research Topic: Original Research, Systematic Review, Methods, Review, Mini Review, Policy and Practice Reviews, Clinical Trial, Community Case Study, Brief Research Report, Technology and Code.
Keywords: digital health, #CollectionSeries, Women in Science, Outcomes Research, Real-World Evidence, Patient-Centered Research, Integrated Care, Value-Based Health Care
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.